| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $40.4M | -49.5% |
| R&D Expense | $134.7M | +5.7% |
| SG&A Expense | $37.5M | +4.5% |
| Operating Income | -$131.8M | -58.3% |
| Pre-tax Income | -$119.6M | -85.9% |
| Income Tax | $144K | -78.3% |
| Net Income | -$119.7M | -84.2% |
| EPS (Basic) | -$2.04 | -80.5% |
| EPS (Diluted) | -$2.04 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.3M | -8.5% |
| Short-term Investments | $131.1M | -32.9% |
| Accounts Receivable | $1.8M | +17.1% |
| Current Assets | $202.7M | -26.8% |
| Total Assets | $252.3M | -35.8% |
| Current Liabilities | $26.5M | -46.7% |
| Total Liabilities | $56.2M | -39.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$132.5M | -765.2% |
| Capital Expenditures | $2.6M | -26.3% |
| Investing Cash Flow | $125.4M | +232.2% |
| Financing Cash Flow | $816K | -99.3% |
| Free Cash Flow | -$135.1M | -617.2% |
| -80.5% |
| Stockholders' Equity |
| $196.1M |
| -34.6% |